ArticleFrontiers in cardiovascular medicine2018

Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation.

Jesus Paez-Mayorga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.